Drug Guide

Generic Name

Methylprednisolone

Brand Names Medrol

Classification

Therapeutic: Anti-inflammatory, Immunosuppressant

Pharmacological: Glucocorticoid

FDA Approved Indications

Mechanism of Action

Methylprednisolone binds to glucocorticoid receptors, resulting in modulation of gene expression that suppresses inflammation and immune responses.

Dosage and Administration

Adult: Dose varies based on condition; commonly 4-48 mg daily, divided doses; adjust based on response and severity.

Pediatric: Dosing is weight-based; usually 0.05-2 mg/kg/day in divided doses.

Geriatric: Use with caution; start at lower end of dosing range due to increased risk of side effects.

Renal Impairment: Adjust dose based on severity of impairment, closely monitor response.

Hepatic Impairment: No specific adjustment recommended, but monitor for enhanced effects or toxicity.

Pharmacokinetics

Absorption: Rapidly absorbed after oral administration.

Distribution: Widely distributed, crosses the placenta, and enters breast milk.

Metabolism: Metabolized hepatically via CYP3A4.

Excretion: Primarily excreted in urine as metabolites.

Half Life: Approximately 18-36 hours.

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

N/A

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor blood pressure, electrolytes, blood glucose, signs of infection, and bone density during long-term therapy.

Diagnoses:

  • Impaired tissue perfusion related to corticosteroid effects
  • Risk of infection due to immunosuppression
  • Potential for fluid volume overload

Implementation: Administer with food to reduce GI irritation; taper dose gradually to prevent adrenal insufficiency.

Evaluation: Assess effectiveness in controlling inflammatory symptoms; monitor side effects.

Patient/Family Teaching

Special Considerations

Black Box Warnings:

Genetic Factors: None specific.

Lab Test Interference: May induce false elevation of blood glucose and eosinophil count.

Overdose Management

Signs/Symptoms: Fluid retention, hyperglycemia, hypertension, hypokalemia.

Treatment: Discontinue corticosteroid gradually; symptomatic and supportive care; manage electrolyte imbalance and blood pressure.

Storage and Handling

Storage: Store at room temperature away from light and moisture.

Stability: Stable for 2-3 years when stored properly.

This guide is for educational purposes only and is not intended for clinical use.